Frequently Asked Questions

When learners complete drug and alcohol testing training, they receive a qualification certificate. To prove their eligibility to collect specimens for drug and alcohol testing, collectors must be ready to provide documentation to DOT agency inspectors, employers, and employer-designated service agents, including C/TPAs.

Qualification documentation should detail their initial training and proficiency demonstration. Examples include certificates and signed letters from the qualified trainer who conducted the mandatory mock collections, confirming that the collectors have completed initial proficiency and the mandatory mock collection as required by regulation 40.33(g).

To qualify for a DOT urine collector, you must complete a minimum of five mock collections. These mock collections should include the following scenarios:

• A routine collection.
• A collection with a refusal scenario.
• A collection with an employee requires a directly observed collection.
• A collection with a shy bladder situation.
• Any other scenario that might commonly occur during a urine collection process.
• Each mock collection must be performed under the supervision of a qualified instructor, who will ensure that you follow all proper procedures and demonstrate competency in handling each scenario.

Proper mock collections for drug and alcohol testing proves that learners have acquired the necessary skills to conduct accurate and reliable tests, and simulating the collection process enables trainees to practice and demonstrate proficiency in handling specimens, maintaining the chain of custody, and adhering to regulatory procedures.

Drug and alcohol abuse can have serious consequences, affecting both individuals dealing with addiction and employers. These issues are particularly concerning in the transportation sector, as they can compromise a driver's ability to safely transport passengers and lead to accidents, injuries, and legal repercussions. DOT (Department of Transportation) drug testing supervisor training is essential to address these challenges.

Who needs DOT drug testing supervisor training? According to U.S. government regulations, any supervisor responsible for referring employees for drug and alcohol testing must complete a qualifying training program. Furthermore, all transportation companies must adhere to these rules regardless of their size. In the past, smaller companies with fewer than 50 covered employees could opt out, but this changed in the late 1990s.

It's not limited to supervisors alone. The government mandates that all transportation safety personnel, dispatch personnel, HR employees, truck drivers, and training instructors complete a qualifying course.

While DOT drug testing supervisor training programs may vary among providers, they must meet specific criteria. All courses must be at least 120 minutes long, with 60 minutes dedicated to alcohol abuse and another 60 minutes to controlled substance use and abuse. In these sessions, attendees will learn how to:

• Understand the impact of drug and alcohol abuse
• Recognize the potential consequences of unreported abuse
• Implement and enforce company-wide alcohol and drug use policies
• Report employees suspected of drug and alcohol abuse

DOT drug testing supervisor training aims to create a safer environment and provide support to employees struggling with substance abuse or alcohol addiction. If you work for a DOT-regulated company, chances are that this training is required. Enroll in a qualified program today to ensure compliance with federal and state mandates.

Reasonable suspicion training is mandatory for workplace safety and compliance, especially in sectors regulated by the Department of Transportation (DOT) and non-DOT-regulated industries. As outlined in 49 CFR Part 40, this training is necessary to establish clear standards for reasonable suspicion among DOT-regulated employers.

In non-DOT sectors, reasonable suspicion training is just as important. While no specific federal regulations like the DOTs exist, this training equips employers and supervisors with the knowledge and skills to identify and manage situations where an employee might be under the influence of drugs or alcohol. This ensures a safe and productive workplace and helps businesses establish policies and procedures that align with state laws and best practices.

Reasonable suspicion training involves making "articulable observations that can be objectively verified by some documentation, which, taken together with rational inferences from those observations, reasonably warrant further investigation." This is used to determine if an employee is under the influence of drugs or alcohol and can serve as sufficient grounds for reasonable suspicion testing.

Supervisors and managers in the following industries must undergo this training once in their lifetime, except for the FAA, which requires annual recurrent training for supervisors:

• Federal Motor Carrier Safety Administration (FMCSA)
• Federal Aviation Administration (FAA)
• Federal Transit Administration (FTA)
• Federal Railroad Administration (FRA)
• United States Coast Guard (USCG)
• Pipeline and Hazardous Materials Safety Administration (PHMSA)

Non-DOT Reasonable Suspicion Training is designed for supervisors in non-regulated industries and is similar to DOT training. It provides workplace supervisors with the legal knowledge to conduct drug and alcohol testing according to company policies and state laws. It ensures adherence to company guidelines and existing legal standards, helps maintain workplace safety, maintains consistent testing procedures, and reduces the risk of discrimination lawsuits.

The expanding focus on workplace safety and maintaining a drug and alcohol-free environment has created new career and business opportunities, including the role of a Breath Alcohol Technician (BAT). BATs conduct breath alcohol tests to determine impairment, essential for safety in industries regulated by the Department of Transportation (DOT).

Training

To become a BAT, you must complete a qualifying training course. Course duration varies, with in-person training lasting up to seven hours and online courses typically shorter. The course covers equipment use, measurement reading, calibration, and managing individuals during tests. For those working with DOT-regulated companies, the training must comply with CFR Part 40 Regulations and can be done on most modern DOT Breath Alcohol Testing devices (Breathalyzers).

Mock Collections

Qualification training, often called "Certification training," requires performing up to seven mock collections, simulating breath alcohol tests under a qualified instructor's observation. These mock collections not only officially qualify the technician to perform testing but also help them competently handle the equipment, follow procedures, and record results accurately.

Refresher Training

Breath Alcohol Technicians must undergo refresher training every five years to maintain their certification and stay up-to-date with the latest procedures and regulatory changes. This process involves retaking the initial training course, which covers the fundamental aspects of breath alcohol testing, including equipment use, measurement reading, device calibration, and managing individuals during tests.

In addition to the course, BATs must complete another mock test series. These mock tests are crucial as they allow technicians to demonstrate their ongoing competency in handling the testing equipment, following proper procedures, and accurately recording results. By completing these mock tests under the supervision of a qualified instructor, technicians can ensure they continue to meet industry and regulatory standards.

Refresher training helps maintain high standards of testing accuracy and reliability, ensuring that all breath alcohol tests are conducted in accordance with the latest best practices and legal requirements. This continuous education is essential for upholding workplace safety and compliance across DOT-regulated and non-DOT-regulated environments.

Risks of Not Being Properly Qualified

Not being properly qualified as a Breath Alcohol Technician carries significant risks. Inaccurate test results can lead to false positives or negatives, potentially allowing impaired individuals to continue working in safety-sensitive positions or wrongly penalizing sober employees. This compromises workplace safety and increases the likelihood of accidents and injuries, and testing without being properly qualified will result in non-compliance with federal regulations, such as those mandated by the DOT, and can result in severe legal repercussions, including fines, sanctions, and lawsuits from employees claiming wrongful termination or discrimination.

Employers have valid reasons to consider workplace drug testing. It's a win-win for both employers and employees, helps companies reduce insurance costs, and is vital for ensuring workplace safety. Every employer desires a workforce free from substance abuse.

It is also crucial for employers to remember that drug tests are not just for detecting the use of illegal drugs. Some prescription drugs, such as opioids, can impair an individual's ability to work safely. Opioids are a class of drugs used to treat pain and include morphine, oxycodone, and fentanyl. Recently, there has been an increase in Americans addicted to opioids, which is a severe problem because addiction to opioids can lead to debilitating health problems and even death.

The economic toll of drug addiction is substantial, as those who misuse substances tend to have more absenteeism, higher unemployment rates, and contribute to increased workplace accidents and injuries. Research has shown a strong link between alcohol and drug use and increased absenteeism in the workplace. Additionally, there's a notable association between these substances and a higher rate of accidents, especially in the transportation sector. However, the evidence connecting alcohol and drug use to other negative work behaviors is less consistent. While current research suggests some association, it's not substantial enough to draw definitive conclusions. When connections are observed between substance use and counterproductive work behavior, they are typically moderate or weak, even if statistically significant.[1]

Workplace drug-testing programs offer several potential benefits, which include, but are not limited to:

1. They can contribute to enhancing workplace safety by identifying and addressing drug-related impairments that may pose risks to employees and the workplace environment. These programs can also promote employee health and well-being by identifying individuals who may be struggling with substance abuse and connecting them with appropriate support and treatment services.[2]
2. Employers can realize significant cost savings by implementing workplace drug testing programs. While initial setup and maintenance of these programs may be viewed as an added expense, they can substantially reduce insurance costs over time. This cost-saving mechanism stems from the improved workplace safety achieved through drug-free employees. By identifying and deterring substance use among their workforce, employers can mitigate the risks associated with drug-related accidents and injuries, ultimately resulting in fewer workers' compensation claims and lower insurance premiums. Workplace drug testing fosters a safer work environment and translates into tangible financial benefits for employers by reducing insurance-related expenditures. In some states, drug-free workplaces can save up to 50% on workers' compensation premiums. 
3. Workplace drug testing programs are the potential reduction in employee turnover costs. These programs, which include pre-employment and ongoing drug testing, contribute to a more stable and reliable workforce. Drug-free employees are less likely to engage in behavior that could lead to disciplinary actions or resignations related to substance abuse. Consequently, employers experience lower turnover rates, translating into decreased expenditures on recruitment, training, and onboarding new employees. This cost-saving measure proves particularly advantageous in the long term, as retaining experienced and skilled workers is often more financially efficient than constantly recruiting and training replacements. Workplace drug testing can play a crucial role in enhancing an organization's financial stability and overall operational efficiency.
4. Workplace drug tests can also help identify employees who have substance abuse problems. Once these employees have been identified, the company can provide the necessary assistance to help with treatment. Drug testing is essential because it can help improve the workplace's safety and prevent accidents. In addition, employees who know that they will be randomly drug tested are less likely to take drugs or be under the influence of drugs or alcohol while at work. This can help employees stay safe by preventing accidents resulting in injuries, fatalities, or expensive property damage.

Employee drug testing, supplemented with reasonable suspicion training, is vital in creating a safer work environment, promoting employee well-being, and reducing insurance costs over time.  Employers looking to establish a stable, dependable workforce with lower turnover rates can reap significant financial benefits from these initiatives and can effectively identify and address substance abuse issues among employees, enhancing workplace safety and accident prevention.

Drug testing laws directly affect how employers maintain a safe, compliant, and productive work environment. By clarifying who can be tested, when tests may occur, and which substances can be screened, these laws help ensure fair treatment of employees, reduce legal exposure and create opportunities for cost-saving incentives. Most importantly, ongoing training and education in this area empower employers to stay current with ever-evolving regulations.

A Brief History of Drug Testing

Federal oversight of workplace drug testing began in earnest with the Drug-Free Workplace Act of 1988, requiring certain federal contractors and grantees to uphold drug-free policies. Since then, each state has introduced its own rules, creating a complex landscape of laws governing testing methods, employee rights, and allowable policies. For example:

• California, Minnesota, and Vermont have stricter regulations, often limiting when and how testing can occur.
• Florida and Texas, on the other hand, offer more flexibility, allowing employers greater control while still following core guidelines.

The Costs of Non-Compliance

Ignoring or misunderstanding drug testing laws can be costly. Employers may face:

• Legal Liability: Discrimination claims can arise if employees face penalties for legally prescribed medications (e.g., medical marijuana).
• Negligent Hiring Lawsuits: Without proper testing, placing an unqualified individual in a safety-sensitive role could lead to serious accidents and subsequent litigation.
• Financial Penalties: Non-compliance can result in fines, sanctions, and damage to an organization’s reputation.

Financial Benefits

Staying compliant doesn’t just prevent problems—it can also improve the bottom line. Many states incentivize employers to maintain drug-free workplaces:

• Insurance Discounts: Employers in states like Florida, Georgia, and Tennessee may qualify for workers’ compensation premium reductions when they establish state-approved drug testing programs.
• Reduced Indirect Costs: A well-managed, drug-free workplace tends to have fewer accidents, reduced absenteeism, and increased productivity, all of which contribute to long-term savings.

State-Specific Considerations

Laws differ significantly from one state to the next, making training and continued education vital. For instance:

• Marijuana Regulations: In states like New York and Arizona, employees with medical marijuana prescriptions enjoy protections, whereas states like Florida maintain zero-tolerance policies.
• Testing Methods: Instant testing (e.g., saliva or urine) may be restricted in states like California or Minnesota unless conducted under specific protocols.

Staying Compliant

Employers can confidently navigate this legal landscape by taking proactive steps:

• Create a Clear Policy: Draft a written drug testing policy that meets federal and state standards.
• Stay Informed: Track changing laws, mainly as marijuana legalization evolves.
• Invest in Training: Enroll in workplace drug and alcohol testing courses to gain state-specific knowledge and identify financial incentives for compliance.

By understanding and adhering to drug testing laws, employers protect their workforce, avoid unnecessary legal and financial risks, and potentially unlock cost-saving opportunities. Ongoing training, policy refinement, and a commitment to staying informed ensure a safer, more productive, and fully compliant workplace.

DOT drug tests are federally regulated with strict guidelines for specific transportation industries, ensuring uniformity and compliance across safety-sensitive positions. These tests follow the Department of Transportation (DOT) standards, which include specific procedures, chain-of-custody protocols, and the use of certified laboratories to screen for substances like marijuana, cocaine, opioids, amphetamines, and PCP.

Non-DOT drug tests are governed by individual company policies and state laws, providing more flexibility in testing procedures and the range of substances screened. Non-DOT tests can include a broader spectrum of drugs, such as benzodiazepines and barbiturates, tailored to the specific needs and regulations of the employer.

Training in drug and alcohol testing is required to ensure drug screen compliance with both DOT and non-DOT. Training teaches collectors the specific procedures for DOT-regulated industries to maintain proper chain-of-custody, maintain compliance with federal regulations, and safeguard public safety. For non-DOT settings, adequate training also helps establish consistent and effective testing protocols that align with company policies and state laws. This training ensures the accuracy and reliability of test results, supports workplace safety, and minimizes legal risks by ensuring adherence to established guidelines and procedures.

The difference between DOT and non-DOT drug tests lies primarily in the regulatory standards and the industries they apply to:

Regulatory Authority:

• DOT Drug Tests: These tests are regulated by the Department of Transportation (DOT) and are mandated for employees in safety-sensitive positions within transportation industries, such as trucking, aviation, railroads, transit, and pipelines. The regulations are outlined in 49 CFR Part 40.
• Non-DOT Drug Tests: These tests are not regulated by the DOT. Instead, they are conducted according to company policies and state laws. Non-DOT tests apply to employees in industries outside the scope of DOT regulations.

Testing Procedures:

• DOT Drug Tests: Follow strict procedures and guidelines set by the DOT, including specific testing protocols, chain-of-custody requirements, and the use of certified laboratories. The test typically screens for five substances: marijuana, cocaine, opioids, amphetamines, and PCP.
• Non-DOT Drug Tests: The procedures vary widely depending on the employer's policies and state regulations. These tests can screen for a broader range of substances beyond the DOT's five-panel test, including additional drugs like benzodiazepines, barbiturates, and others.

Documentation and Reporting:

• DOT Drug Tests: Require detailed documentation and reporting to ensure compliance with federal regulations. Positive results must be reviewed by a Medical Review Officer (MRO) and reported to the appropriate DOT agency.
• Non-DOT Drug Tests: Documentation and reporting are determined by the employer's policy and applicable state laws. There may be less stringent documentation requirements compared to DOT tests.

Consequences of Positive Results:

• DOT Drug Tests: Positive results can lead to immediate removal from safety-sensitive duties, mandatory evaluation by a Substance Abuse Professional (SAP), and completion of a return-to-duty process before resuming safety-sensitive functions.
• Non-DOT Drug Tests: Consequences of positive results vary by employer and state law. Employers may have more flexibility in handling positive tests, including disciplinary actions, rehabilitation programs, or termination.

Frequency of Testing:

• DOT Drug Tests: Employees are subject to various types of testing, including pre-employment, random, post-accident, reasonable suspicion, return-to-duty, and follow-up testing, all following DOT guidelines.
• Non-DOT Drug Tests: Testing frequency and types depend on the employer's policies. While some companies may adopt testing categories similar to the DOT, others may have different requirements.

DOT drug tests are federally regulated with strict guidelines for specific transportation industries. In contrast, non-DOT drug tests are governed by individual company policies and state laws, offering more flexibility in testing procedures and substances screened.

Hair dye will not typically result in a negative drug test. Hair drug tests are designed to analyze the chemical structure of the hair for traces of drugs and their metabolites, which become embedded in the hair shaft as it grows. While hair dye can change the color and appearance of hair, it generally does not affect the presence of drug metabolites within the hair shaft itself.

However, some hair treatments, such as bleaching or heavy chemical processing, might potentially impact the hair sample's integrity and affect the test results. It is important to note that most standard hair dyeing processes do not interfere with the detection of drugs.

For accurate results, always inform the testing facility about any hair treatments you have recently undergone, including dyeing or chemical treatments. Proper drug and alcohol testing training ensures that technicians are aware of these factors and can account for them during the testing process, maintaining the reliability and accuracy of the results.

A reasonable suspicion checklist can be invaluable for employers, particularly in maintaining a safe, productive, and drug-free workplace, and provides guidelines for recognizing and addressing situations where there's reasonable suspicion of an employee's drug or alcohol impairment, all employers need to understand its role, implementation, and potential benefits.

In employment, reasonable suspicion is a legal standard employers use when they believe an employee might be impaired due to drug or alcohol use. The suspicion is usually based on direct observations, such as appearance, behavior, speech, or body odors, and identifying these signs can be challenging, especially when balancing respect for employees' privacy and maintaining a safe work environment, where a reasonable suspicion checklist comes into play.

Using a checklist for reasonable suspicion determinations offers a systematic way to observe and document signs of possible substance abuse, which assists employers in making informed decisions, and a list typically outlines physical, behavioral, and performance indicators of potential impairment. For example, sudden changes in work performance, unusual behavior, or physical signs such as bloodshot eyes could all indicate substance abuse, and by providing a structured format to note down and assess these factors, the checklist aids in ensuring that the decision to test an employee is indeed 'reasonable' and not arbitrary, biased, or unfounded.

Checklists also promote consistency and fairness in dealing with suspected substance abuse cases, and every manager or supervisor uses the same criteria for identifying signs of impairment. In that case, it helps prevent unfair targeting of individuals and ensures everyone is treated equally, and consistency is crucial in avoiding legal complications arising from perceived discrimination or violating an employee's rights.

Another significant benefit of using a reasonable suspicion checklist is its role in fostering a safer workplace, and when effectively used, the checklist can help identify employees who may pose a risk to themselves or others due to impairment, and by these situations promptly, employers can prevent accidents, injuries, and other safety issues, protecting the company and its employees.

We invite you to download our free checklist to create a safer, more respectful workplace. It's a practical, user-friendly tool designed to help employers navigate the complex process of identifying and handling suspected substance abuse in the workplace, and by providing clear guidance and promoting a standardized approach, our checklist empowers you to address these sensitive issues with certainty and compassion.

The free checklist is not a substitute for legal advice. Always consult an attorney for your unique situation.

Failing to complete reasonable suspicion training can lead to multiple consequences, including increased risks of oversight, non-compliance with regulations, potential legal ramifications, and jeopardized safety. It's essential to understand the importance and requirements of this training to ensure optimal outcomes in relevant scenarios.

Managers and supervisors are legally required to complete reasonable suspicion training if they are part of a DOT agency, and USCG regulations require the training to be completed[1]. However, as a busy employer, you may wonder why you must train your supervisors when they have many other responsibilities to complete. Unfortunately, the consequences of your staff forgoing this training are varied and vast. While the consequences start with law violations, they certainly do not end there.

Fines & Fees

If your supervisors are not trained in reasonable suspicion when it is necessary for them to be, you are in clear violation of the law and are subject to fines and fees until compliance is met[2]. These fines vary depending on the industry and the number of people that are found in violation of the law. However, these fines are inconsequential when compared to the more serious ramifications of under-trained supervisors.

Improper Documentation Can Lead to Lawsuits

Personal privacy is an employee’s right that is sensitive and easy to accidentally violate when proper training has not been implemented[3]. There are several ways in which a supervisor can cross the line when it comes to drug testing. When it comes down to word against word, the documentation that was recorded by the supervisor will be essential in protecting a business from litigation. When a supervisor orders a drug test, they must ensure that their documentation is written with attention to detail[4].

Details that must be included are:

Information on when and where the employee was observed. What was observed to raise suspicions? Observations can range from erratic behavior to twitchy movement, strange speech patterns, emotions, physical appearance, or simply inaction like sleeping or a lack of reaction to questions[5]. The secondary trained manager, supervisor, or company official was asked to assess the observation to determine if the suspicion is valid. The actions are taken to protect the employee and his or her surroundings, such as removing them from safety-sensitive areas.

The documentation must be specific, non-accusatory, and packed with observations that can be interpreted as reasonable suspicion. Supervisors are taught the specifics of documentation in reasonable suspicion training.

If your company is taken to court, lawyer fees and potential settlement costs can range in the hundreds of thousands, if not the millions.

Incorrectly Handling a Situation with an Employee Can Lead to Uncomfortable Situations

It can be very difficult to properly handle situations with employees, especially if a supervisor does not naturally have the skills to deal with the varied responses of an employee who may feel defensive. When an employee is approached about a situation or behavior that triggers a supervisor to feel suspicious, reactions can range from fear to sadness and aggression. Part of reasonable suspicion training involves giving a supervisor tools to deal with uncomfortable and tricky situations[6], making the situation more likely to be safe for all parties. If a supervisor does not have those tools, a situation can escalate when an employee becomes violent or otherwise difficult to deal with, which endangers both employee and supervisor.

Not Recognizing the Signs of Drug or Alcohol Abuse Can Result in Accidents

If an employee is good at hiding their drug or alcohol addiction, they may appear sound of mind to anyone who does not have a trained eye. Signs can vary from slight mood swings, changes in work attendance, unusual behavior when not directly in the presence of a supervisor, and other smaller, less visible signs, and a missed alcohol or drug impairment can cause accidents that result in injury or equipment damage and the death of the employee and others involved in an accident. Not only is this an avoidable tragedy, but it is also costly for all involved. An effortless way to ensure that your employees and supervisors are as safe as possible is to ensure that all managers in charge of employees complete the necessary two to three hours of training.

Arkansas has codified its workplace drug testing laws under the Arkansas Statute §11-14-101 to §11-14-115. These laws offer detailed guidelines for employers, ensuring that drug testing is carried out with fairness and respect for the rights of employees. By following these statutes, employers can ensure they operate within the legal framework.

Marijuana in Arkansas: Medical marijuana is legal and requires a prescription from a licensed physician. Recreational use remains illegal.

You can review the specific statutes here.

Please note: The provided information serves as a general overview. Always consult with local legal experts or review state-specific legal resources for detailed and current information.

Vermont has framework for drug testing employees, emphasizing the rights and protections of workers. The Vermont Fair Employment Practices Act and the specific statutes under Title 21 outline the legal landscape for drug and alcohol testing in the state.

Marijuana in Vermont: Recreational marijuana use is legal in Vermont. However, employers are not required to accommodate its use in the workplace. Medical marijuana is also legalized and regulated separately.

For in-depth information, one can refer to the Vermont Fair Employment Practices Act and the provisions on drug testing in Title 21.

RST Certification, an acronym for Reasonable Suspicion Training Certificate, training plays a critical role within the Department of Transportation's (DOT) regulatory framework and is a mandatory requirement for supervisors and managers across all DOT-regulated industries.

Its primary objective is to provide supervisors with the skills and knowledge necessary to promptly recognize indicators of drug or alcohol misuse among employees in safety-sensitive positions. This capability is pivotal in facilitating timely intervention and maintaining a secure workplace environment and is mandatory for supervisors and managers.

RST certification training covers 60 minutes for making drug testing reasonable cause determinations and 60 minutes for assessing reasonable suspicion for alcohol testing, totaling 2 hours. This training focuses on specific, real-time, well-articulated observations encompassing appearance, speech, behavior, and body odor.

Employees subject to DOT drug and alcohol testing must complete Reasonable Suspicion Training as a part of their ongoing commitment to safety and compliance within their respective transportation sectors. Both employers and employees within DOT-regulated industries must stay updated on the latest training requirements and guidelines specific to their roles and modes of transportation to ensure full compliance with DOT regulations.

While DOT regulations mandate training for supervisors overseeing DOT-regulated activities, it's important to recognize that earning an RST training certificate in non-DOT industries is equally valuable, and although not federally mandated, enrolling supervisors in such training equips them with the essential skills and tools to identify early signs of substance misuse. This proactive approach enhances workplace safety, reduces potential liability risks, bolsters productivity, and cultivates a culture of responsibility and compliance, making it a prudent investment for employers in various sectors.

The Department of Transportation (DOT) in the United States regulates various industries and modes of transportation to ensure safety, compliance, and efficient transportation systems. The DOT oversees several agencies, each responsible for specific sectors. Here are some of the industries and modes of transportation regulated by the DOT:

• Aviation: The Federal Aviation Administration (FAA), a branch of the DOT, regulates civil aviation, including commercial and private aircraft, airports, and air traffic control.
• Highways and Motor Carriers: The Federal Motor Carrier Safety Administration (FMCSA) regulates commercial motor vehicles, trucking companies, and bus transportation. This includes regulations for truck drivers, motor carriers, and safety standards.
• Railroad: The Federal Railroad Administration (FRA) oversees safety and operations in the railroad industry, including freight and passenger rail.
• Public Transportation: The Federal Transit Administration (FTA) focuses on public transportation systems, such as buses, subways, light rail, and commuter rail systems.
• Maritime: The Maritime Administration (MARAD) deals with the maritime industry, including shipping, ports, and shipbuilding.
• Pipeline: The Pipeline and Hazardous Materials Safety Administration (PHMSA) regulates the transportation of hazardous materials via pipelines and other means.

RST Certification is crucial in DOT-regulated industries for maintaining safety and compliance. It's equally beneficial in non-DOT sectors, enhancing safety, reducing liability, and promoting responsibility. The DOT oversees a wide range of industries to ensure safety and efficiency.

An observed collection is a specific drug test procedure where a trained observer directly watches the donor's urine sample. This is crucial to prevent tampering or substitution of the urine specimen. The observer ensures the sample's integrity by following strict guidelines:

• Instructing the donor to raise their clothing above the waist and lower their pants and underpants to mid-thigh to check for any tampering devices.
• Watching the urine go from the donor's body into the collection container without losing sight of the container.
• Ensuring the donor does not turn away or conceal the collection process.
• Observed collections are typically required when there is a suspicion of specimen tampering, following a prior invalid test result, or as part of a return-to-duty or follow-up testing program. The observer must be the same gender as the donor, and all procedures must respect the donor's privacy while maintaining the collection's integrity.

Proper training in drug and alcohol testing helps collectors understand when and how to conduct observed collections correctly, maintaining the integrity of the testing process and complying with regulatory requirements. This knowledge helps avoid errors and ensures that all procedures are followed precisely, protecting both the donor's rights and the accuracy of the test results.

Reasonable Suspicion Training in Canada, commonly called RST training, is a specialized compliance course designed to educate supervisors, managers, and employees on identifying and appropriately responding to signs of substance abuse and impairment in the workplace. This training provides individuals with the skills needed to observe, document, and address situations where an employee may be under the influence of drugs or alcohol, ensuring that any actions taken are based on reasonable and legally defensible suspicion.

This training type is required to maintain a safe and productive work environment, and by learning to recognize the signs of impairment, supervisors can take timely and appropriate actions to prevent accidents, injuries, and other safety incidents that may arise from substance abuse. It also helps comply with workplace safety regulations and policies, protecting employees and the organization from potential legal liabilities.

Reasonable Suspicion Training contributes significantly to workplace safety by:

• Preventing Accidents and Injuries: Trained supervisors can identify impairment before it leads to dangerous situations, reducing the risk of accidents and injuries.
• Maintaining Productivity: By promptly addressing substance abuse issues, workplaces can maintain higher productivity and efficiency.
• Promoting a Safe Work Culture: It fosters an environment where safety is prioritized, and employees know that substance abuse will not be tolerated.
• Legal and Regulatory Compliance: Ensures the organization adheres to safety regulations and avoids potential legal consequences.
  Similarity to the US Requirements

Reasonable Suspicion Training for Canadian employees is similar to the training required in the United States. Both countries emphasize the importance of this training in ensuring workplace safety and compliance with respective regulations. The principles of observing, documenting, and acting upon signs of impairment are consistent across both jurisdictions.

By investing in quality training from a reputable provider, organizations can be confident that their staff is well-prepared to maintain a safe and compliant workplace. A reputable training provider offers an approved curriculum that covers all necessary aspects of recognizing and handling reasonable suspicion situations. They employ experienced instructors who understand the nuances of substance abuse and workplace safety, ensuring that the training meets all regulatory requirements. Additionally, reputable providers offer ongoing support and resources even after the training session is completed, further enhancing the effectiveness and sustainability of the training program.

Recent developments suggest a possible shift in how federal authorities treat marijuana within the United States. The Drug Enforcement Administration (DEA), responsible for classifying substances into various schedules, will hold formal hearings beginning in January 2025. 

These hearings will assess whether marijuana should remain in its current category, which places it among substances considered to have no accepted medical use and a high risk for misuse, or whether it should be relocated to a category (commonly referred to as Schedule III) that acknowledges recognized medical applications.

For decades, the federal stance on marijuana has remained relatively fixed. The possibility of adjusting its status at this level is noteworthy and indicates that perceptions regarding marijuana have evolved. While the outcome of these hearings remains uncertain, their existence demonstrates that prior assumptions are being reexamined in light of emerging research and changing public sentiment.

Historical Context: How We Got Here

The Controlled Substances Act and Schedule I Classification

In 1970, Congress passed the Controlled Substances Act (CSA), establishing a framework for regulating drugs based on their medical utility and abuse potential. Marijuana was classified as a Schedule I substance, the most restrictive category, alongside heroin and LSD. This designation indicated that marijuana was considered to have:

• A high potential for abuse,
• No accepted medical use in treatment, and
• A lack of accepted safety for use under medical supervision.

This classification has remained controversial for over 50 years, as research has emerged suggesting the therapeutic benefits of cannabis in treating conditions such as chronic pain, epilepsy, and nausea from chemotherapy.
The Fight for Rescheduling

Since the 1970s, advocates have pushed for marijuana to be removed or rescheduled within the CSA. Key milestones include:

• 1972 NORML Petition: The National Organization for the Reform of Marijuana Laws (NORML) filed a petition to reschedule marijuana. After 22 years of litigation, the DEA rejected the petition in 1994, stating that marijuana lacked a "currently" accepted medical use."
• 1996 State Legalization Efforts: California became the first state to legalize medical marijuana with Proposition 215. Over the next two decades, dozens of states followed suit, creating a patchwork of state laws inconsistent with federal policy.
• 2011 Coalition for Rescheduling Cannabis Petition: This petition brought renewed attention to marijuana's status, but the DEA rejected it in 2016, citing insufficient evidence of medical use.
• Public and Scientific Shifts: By the late 2010s, public opinion had dramatically shifted. A Pew Research Center survey in 2021 found that 91% of Americans supported either medical or complete legalization of marijuana. Simultaneously, research began to challenge earlier views about marijuana and its medical efficacy.

In the Biden Administration's October 2022, President Biden called on the Secretary of Health and Human Services (HHS) and the Attorney General to review marijuana. This marked a significant turning point, as the HHS subsequently recommended rescheduling marijuana to Schedule III in 2023. This recommendation acknowledged that:

• Marijuana has an accepted medical use,
• Its potential for abuse is lower than Schedule I or II drugs, and
• Its abuse may lead to moderate or low physical dependence.
• The DEA initiated formal rulemaking in 2024, culminating in the upcoming 2025 hearings.

The 2025 Hearings

Witness testimony is scheduled from January 22 through the week of March 3, 2025, occurring every Tuesday, Wednesday, and Thursday. These hearings aim to gather factual evidence and expert opinions to determine whether marijuana should be reclassified as a Schedule III substance. This reclassification would:

• Acknowledge its medical uses,
• Reduce barriers to research and
• Subject marijuana to less stringent regulatory controls.

However, the DEA remains unclear, and the process will likely involve extensive stakeholder debate. Rescheduling marijuana has significant implications for professionals in workplace compliance, healthcare, and law enforcement. Continuing education is essential for adapting to these changes and ensuring the effective implementation of policies.

Implications for Employers

Should the DEA adopt a new stance on marijuana, employers and professionals in fields related to workplace safety and regulatory compliance may need to reevaluate their current policies. For example:

• Policy Revisions: Employers rely on federal schedules to guide their internal substance policies. Altering marijuana policies may prompt employers to update their testing protocols, clarify permissible use under medical guidelines, and ensure adherence to state and federal regulations.
• Interpreting Conflicting Standards: Many states have already introduced varying degrees of legalized marijuana use, creating a complex compliance environment. If federal rules shift, organizations may need to reconcile previously conflicting positions, ensuring that workplace policies align with evolving requirements.
• Staying Informed: As studies on marijuana and applications continue, professionals engaged in compliance, human resources, and legal guidance must remain knowledgeable about changes. A comprehensive understanding will help them address new challenges as the regulatory landscape evolves.
• Professional Education: Marijuana's rescheduling underscores the need for ongoing education for legal and compliance professionals. Staying updated on regulations, science, and policies ensures lawful, informed workplace practices. Regular training and certifications help professionals who maintain employ drug-free workplaces or perform drug testing adapt and provide practical guidance in a rapidly evolving regulatory landscape.

What Lies Ahead?

The DEA represents a period of reconsideration for federal marijuana policy. Their conclusion, expected in early 2025, may confirm existing standards, result in a new classification, or prompt additional inquiry. In each scenario, the implications extend beyond law enforcement. They touch upon how employers manage personnel, how medical professionals advise patients, and how the public interprets marijuana use's benefits and potential drawbacks.

In the coming months, stakeholders, from corporate counsel to the human resources team, would be well advised to monitor these developments. As events unfold, the ability to adapt policies and practices to reflect updated federal guidelines will prove essential. The hearings mark a turning point and serve as a reminder that what was once considered settled law may now be subject to reconsideration in an evolving regulatory climate.

No. Currently, there is no situation in which a What is a Medical Review Officer? (MRO) can verify a laboratory confirmed marijuana positive drug test result as negative when an employee claims the positive came from using a state-licensed marijuana product.

Even after rescheduling, state-dispensed marijuana does not constitute an FDA-approved drug. Without FDA approval for a controlled substance, it cannot be prescribed. A legitimate medical explanation requires the use of a legally prescribed controlled substance in compliance with Federal laws governing such a prescription (49 CFR sections 40.137(a) and 40.141(b)).

Although the MRO may be presented with documentation such as state-issued medical marijuana cards, physician recommendations, certifications, or dispensary records or receipts, these documents do not satisfy Part 40 requirements for a legitimate medical explanation. Marijuana use under state marijuana programs or other non-prescription sources does not qualify as a legitimate medical explanation under 49 CFR section 40.137(a). In addition, marijuana use is not compatible with safety-sensitive functions.

Here are some practical examples. A commercial truck driver in Colorado holds a state medical marijuana card and uses a licensed dispensary product for pain management. After a random DOT urine test returns positive for marijuana metabolites, the driver provides the card and purchase receipts to the MRO. The MRO cannot accept this as a legitimate medical explanation and must report the result as positive, triggering DOT return-to-duty requirements.

Practical Use Cases

• Commercial Truck Driver: A driver in Colorado holds a state medical marijuana card and uses a licensed dispensary product for pain management. After a random DOT urine test returns positive for marijuana metabolites, the driver provides the card and purchase receipts to the MRO. The MRO cannot accept this as a legitimate medical explanation and must report the result as positive, triggering DOT return-to-duty requirements. 
• Transit Bus Operator: An employee in a safety-sensitive public transit role tests positive after recreational use of state-legal cannabis. The employee submits a physician's recommendation and dispensary records. Under Part 40, these documents are insufficient; the MRO verifies the result as positive because state programs do not meet federal prescription standards.
• Pipeline Maintenance Technician: Following a post-accident test, a technician claims the positive came from legally purchased edibles in a recreational state. Even with proof of state-compliant purchase, the MRO has no authority to overturn the laboratory positive, as marijuana remains incompatible with safety-sensitive duties under federal rules.

Even with proof of state-compliant purchase, the MRO has no authority to overturn the laboratory positive as marijuana remains incompatible with safety-sensitive duties under federal rules.

Here you go:

 
A Medical Review Officer (MRO) is the final checkpoint in the drug testing process. They help ensure that results are accurate, legally sound, and fair to all parties involved. MROs are licensed physicians who have received specialized training in substance abuse disorders and the technical aspects of drug testing. In the United States, MROs must meet certification requirements set by organizations such as the American Association of Medical Review Officers (AAMRO) or the Medical Review Officer Certification Council (MROCC).

The MRO's primary role is to review and interpret laboratory drug test results before they are reported to an employer. Key responsibilities include:

• Reviewing laboratory results: The MRO receives all non-negative drug test results directly from the certified laboratory.
• Contacting donors: Before reporting a positive result, the MRO contacts the donor (the person tested) to determine whether there is a legitimate medical explanation, such as a valid prescription.
• Verifying prescriptions: The MRO evaluates any prescription or medical documentation provided by the donor to determine if it is a valid, lawful explanation for the result.
• Making final determinations: The MRO issues a final result of Positive, Negative, Canceled, or Refusal to Test based on all available information.
• Reporting results: The MRO reports the verified, final result to the designated employer representative (DER).
• Protecting donor privacy: MROs handle sensitive medical information and are bound by confidentiality standards.

Many think specimen collectors are MROs, but that is a serious misconception. Specimen collectors gather and process the specimens, but they do not interpret results, and that's where the MRO comes in. 

For DOT-regulated programs, having a qualified MRO in the workflow is required by federal law (49 CFR Part 40), and for good reason. An MRO bridges the gap between a raw laboratory finding and a legally defensible final result by giving donors the opportunity to explain a positive before it's ever reported to an employer, reviewing the chain of custody form to ensure the collection was conducted properly, and determining whether a flawed or rejected specimen should be canceled and a retest ordered.